IN187170B - - Google Patents

Info

Publication number
IN187170B
IN187170B IN12MU2000A IN187170B IN 187170 B IN187170 B IN 187170B IN 12MU2000 A IN12MU2000 A IN 12MU2000A IN 187170 B IN187170 B IN 187170B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Jadav Kanaksinh Dr Jesingbhai
Chitturi Trinadha Dr Rao
Thennati Dr Rajamannar
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Priority to IN12MU2000 priority Critical patent/IN187170B/en
Priority to US09/709,812 priority patent/US6506940B1/en
Priority to PCT/IN2001/000001 priority patent/WO2001049638A2/en
Priority to CH01496/01A priority patent/CH692620A5/de
Priority to AU35979/01A priority patent/AU3597901A/en
Priority to IT2001MI000011A priority patent/ITMI20010011A1/it
Priority to BE2001/0440A priority patent/BE1013214A6/fr
Publication of IN187170B publication Critical patent/IN187170B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN12MU2000 2000-01-04 2000-01-04 IN187170B (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IN12MU2000 IN187170B (fi) 2000-01-04 2000-01-04
US09/709,812 US6506940B1 (en) 2000-01-04 2000-11-10 Process for converting stereoisomers of sertraline into sertraline
PCT/IN2001/000001 WO2001049638A2 (en) 2000-01-04 2001-01-01 A process for converting stereoisomers of sertraline into sertraline
CH01496/01A CH692620A5 (de) 2000-01-04 2001-01-01 Verfahren zur Umwandlung von Sertralin-Stereoisomeren in Sertralin.
AU35979/01A AU3597901A (en) 2000-01-04 2001-01-01 A process for converting stereoisomers of sertraline into sertraline
IT2001MI000011A ITMI20010011A1 (it) 2000-01-04 2001-01-04 Processo per convertire stereoiosomeri di sertralina in sertralina
BE2001/0440A BE1013214A6 (fr) 2000-01-04 2001-07-03 Procede de conversion de stereo-isomeres de sertraline en sertraline.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN12MU2000 IN187170B (fi) 2000-01-04 2000-01-04
US09/709,812 US6506940B1 (en) 2000-01-04 2000-11-10 Process for converting stereoisomers of sertraline into sertraline
BE2001/0440A BE1013214A6 (fr) 2000-01-04 2001-07-03 Procede de conversion de stereo-isomeres de sertraline en sertraline.

Publications (1)

Publication Number Publication Date
IN187170B true IN187170B (fi) 2002-02-23

Family

ID=27159887

Family Applications (1)

Application Number Title Priority Date Filing Date
IN12MU2000 IN187170B (fi) 2000-01-04 2000-01-04

Country Status (7)

Country Link
US (1) US6506940B1 (fi)
AU (1) AU3597901A (fi)
BE (1) BE1013214A6 (fi)
CH (1) CH692620A5 (fi)
IN (1) IN187170B (fi)
IT (1) ITMI20010011A1 (fi)
WO (1) WO2001049638A2 (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723878B2 (en) 2001-06-15 2004-04-20 Orion Corporation Fermion Method for preparing sertraline
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
TW200503991A (en) * 2003-04-14 2005-02-01 Teva Pharma Hydrogenation of imine intermediates of sertraline with catalysts
AU2004265021B2 (en) * 2003-08-18 2010-05-27 H. Lundbeck A/S Succinate and malonate salt of trans-4-(IR,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament
WO2005023752A2 (en) * 2003-09-05 2005-03-17 Teva Pharmaceutical Industries Ltd. A recycling process for preparing sertraline
TWI453198B (zh) * 2005-02-16 2014-09-21 Lundbeck & Co As H 製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s）-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法
TWI376373B (en) * 2005-02-16 2012-11-11 Lundbeck & Co As H Crystalline base of a pharmaceutical compound
MX2007009816A (es) * 2005-02-16 2007-09-07 Lundbeck & Co As H Sales de tartrato y de malato de trans-1-((1r,3s)-6-cloro-3- fenilindan-1-i1)-3,3-dimetilpiperazina.
EP1851189A1 (en) * 2005-02-23 2007-11-07 Teva Pharmaceutical Industries Ltd Processes for preparing sertraline
US7345201B2 (en) * 2005-02-23 2008-03-18 Teva Pharmaceutical Industries, Ltd. Processes for preparing sertraline
CA2576097C (en) 2005-06-03 2009-10-27 Hetero Drugs Limited A highly stereoselective synthesis of sertraline
CA2614282A1 (en) 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
DK2013835T3 (en) * 2006-03-31 2015-12-14 Sunovion Pharmaceuticals Inc Preparation of chiral amides and AMINES
WO2009019412A1 (en) * 2007-08-09 2009-02-12 Npil Pharmaceuticals (Uk) Limited Racemisation process for obtaining (1s,4s) n-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine (sertraline)
NZ589571A (en) * 2008-05-07 2012-07-27 Lundbeck & Co As H Method for treating cognitive deficits using trans-4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine
EP2344163A1 (en) * 2008-10-03 2011-07-20 H. Lundbeck A/S Oral formulation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556676A (en) 1979-11-01 1985-12-03 Pfizer Inc. Antidepressant derivatives of trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4536518A (en) 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4777288A (en) 1987-06-11 1988-10-11 Pfizer Inc. Process for preparing a 4,4-diphenylbutanoic acid derivative
US4839104A (en) 1987-06-11 1989-06-13 Pfizer, Inc. Process for preparing sertraline intermediates
US4855500A (en) 1988-05-04 1989-08-08 Pfizer Inc. Process for preparing a ketimine
US5082970A (en) * 1991-03-06 1992-01-21 Pfizer Inc. Process for recycling amine isomer
US5196607A (en) 1992-02-14 1993-03-23 Pfizer Inc. Process for preparing ketone enantiomer
US5466880A (en) 1992-09-15 1995-11-14 Pfizer Inc. Process for preparing ketone enantiomer
US5750794A (en) 1993-11-30 1998-05-12 Pfizer Inc. Process for preparing chiral tetralone
HU218599B (hu) 1996-10-09 2000-10-28 EGIS Gyógyszergyár Rt. Eljárás 4-(3,4-diklór-fenil)-3,4-dihidro-1-(2H)-naftalin-1-on előállítására
HU222341B1 (hu) 1996-12-18 2003-06-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás sertralin előállítására és az eljárásban alkalmazott intermedier
IN191358B (fi) 1998-01-16 2003-11-29 Pfizer Prod Inc
US6054614A (en) 1998-04-23 2000-04-25 Ciba Specialty Chemicals Corporation Process for the preparation of tetralone imines for the preparation of active pharmaceutical compounds
HU226424B1 (en) * 1998-05-05 2008-12-29 Egis Gyogyszergyar Nyrt Process for producing enantiomer mixture for preparation of sertraline
IL132500A0 (en) * 1998-10-29 2001-03-19 Pfizer Prod Inc Stereoselective microbial reduction of a racemic tetralone

Also Published As

Publication number Publication date
AU3597901A (en) 2001-07-16
BE1013214A6 (fr) 2001-10-02
ITMI20010011A1 (it) 2002-07-04
WO2001049638A3 (en) 2001-12-06
WO2001049638A2 (en) 2001-07-12
CH692620A5 (de) 2002-08-30
US6506940B1 (en) 2003-01-14

Similar Documents

Publication Publication Date Title
BE2017C009I2 (fi)
BE2015C062I2 (fi)
BE2014C035I2 (fi)
BE2012C016I2 (fi)
BE2011C032I2 (fi)
BE2010C019I2 (fi)
BE2010C009I2 (fi)
JP2001045763A5 (fi)
BRPI0110940B8 (fi)
AR028236A3 (fi)
BE2014C025I2 (fi)
IN187170B (fi)
BRPI0113372A8 (fi)
JP2001298910A5 (fi)
JP2001028338A5 (fi)
JP2003504040A5 (fi)
JP2001310690A5 (fi)
JP2002030545A5 (fi)
JP2002148515A5 (fi)
JP2002168248A5 (fi)
JP2001357628A5 (fi)
JP2003505200A5 (fi)
JP2002150047A5 (fi)
BRPI0003419A (fi)
BY5768C1 (fi)